Using High-Resolution MR Imaging at 7T to Evaluate the Anatomy of the Midbrain Dopaminergic System

References

1. 1.↵
   1. Oades R,
   2. Halliday GM

   . Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res 1987;434:117–65

   PubMed
2. 2.↵
   1. Williams S,
   2. Goldman-Rakic P

   . Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex 1998;8:321–45

   Abstract/FREE Full Text
3. 3.↵
   1. Francois C,
   2. Yelnik J,
   3. Percheron G

   . Golgi study of the primate substantia nigra. II. Spatial organization of dendritic arborizations in relation to the cytoarchitectonic boundaries and to the striatonigral bundle. J Comp Neurol 1987;265:473–93

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Grace AA,
   2. Bunney BS

   . The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 1984;4:2877–90

   Abstract
5. 5.↵
   1. Schultz W,
   2. Romo R

   . Dopamine neurons of the monkey midbrain: contingencies of responses to stimuli eliciting immediate behavioral reactions. J Neurophysiol 1990;63:607–24

   Abstract/FREE Full Text
6. 6.↵
   1. Salamone JD

   . The behavioral neurochemistry of motivation: methodological and conceptual issues in studies of the dynamic activity of nucleus accumbens dopamine. J Neurosci Methods 1996;64:137–49

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Ikemoto S,
   2. Panksepp J

   . The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev 1999;31:6–41

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Redgrave P,
   2. Prescott TJ,
   3. Gurney K

   . Is the short-latency dopamine response too short to signal reward error? Trends Neurosci 1999;22:146–51

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Kakade S,
   2. Dayan P

   . Dopamine: generalization and bonuses. Neural Netw 2002;15:549–59

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Schultz W

    . Predictive reward signal of dopamine neurons. J Neurophysiol 1998;80:1–27

    Abstract/FREE Full Text
11. 11.↵
    1. Fearnley JM,
    2. Lees AJ

    . Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283–301

    Abstract/FREE Full Text
12. 12.↵
    1. Tomasi D,
    2. Goldstein RZ,
    3. Telang F,
    4. et al

    . Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence. Brain Res 2007;1171:83–92

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Takahashi H,
    2. Koeda M,
    3. Oda K,
    4. et al

    . An fMRI study of differential neural response to affective pictures in schizophrenia. Neuroimage 2004;22:1247–54

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Murray GK,
    2. Corlett PR,
    3. Clark L,
    4. et al

    . Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry 2008;13:267–76

    CrossRefWeb of Science
15. 15.↵
    1. Duguid J,
    2. Paz RDL,
    3. DeGroot J

    . Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann Neurol 1986;20:744–47

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Snyder AM,
    2. Connor JR

    . Iron, the substantia nigra and related neurological disorders. Biochim Biophys Acta 2009;1790:606–14.Epub 2008 Aug 20

    CrossRefPubMed
17. 17.↵
    1. Shibata E,
    2. Sasaki M,
    3. Tohyama K,
    4. et al

    . Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus. Biol Psychiatry 2008;64:401–06

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Manova ES,
    2. Habib CA,
    3. Boikov AS,
    4. et al

    . Characterizing the mesencephalon using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2009;30:569–74.Epub 2008 Dec 26

    Abstract/FREE Full Text
19. 19.↵
    1. Thomas BP,
    2. Welch EB,
    3. Niederhauser BD,
    4. et al

    . High-resolution 7T MRI of the human hippocampus in vivo. J Magn Reson Imaging 2008;28:1266–72

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Zecca L,
    2. Berg D,
    3. Arzberger T,
    4. et al

    . In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 2005;20:1278–85

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Sofic E,
    2. Riederer P,
    3. Heinsen H,
    4. et al

    . Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 1988;74:199–205

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Connor JR,
    2. Menzies SL

    . Cellular management of iron in the brain. J Neurol Sci 1995;134:33–44

    PubMedWeb of Science
23. 23.↵
    1. Zecca L,
    2. Gallorini M,
    3. Schuenemann V,
    4. et al

    . Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J Neurochem 2001;76:1766–73

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Sasaki M,
    2. Shibata E,
    3. Tohyama K,
    4. et al

    . Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 2006;17:1215–18

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Semnic R,
    2. Svetel M,
    3. Dragasevic N,
    4. et al

    . Magnetic resonance imaging morphometry of the midbrain in patients with Wilson disease. J Comput Assist Tomogr 2005;29:880–83

    CrossRefPubMed
26. 26.↵
    1. Feinberg DA,
    2. Oshio K

    . GRASE (gradient- and spin-echo) MR imaging: a new fast clinical imaging technique. Radiology 1991;181:597–602

    PubMed
27. 27.↵
    1. Bernstein MA,
    2. King KF,
    3. Zhou XJ

    . Handbook of MRI Pulse Sequences. San Diego, California:Elsevier Academic Press;2004:584
28. 28.↵
    1. Li C,
    2. Kao C-Y,
    3. Gore JC,
    4. et al

    . Minimization of region-scalable fitting energy for image segmentation. IEEE Trans Image Process 2008;17:1940–49

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Naidich TP,
    2. Duvernoy HM,
    3. Delman BN,
    4. et al

    . Duvernoy's Atlas of the Human Brain Stem and Cerebellum: High-Field MRI, Surface Anatomy, Internal Structure, Vascularization and 3D Sectional Anatomy. New York:Springer-Verlag/Wien;2009:84–89,356
30. 30.↵
    1. Paxinos G,
    2. Huang X

    . Atlas of the Human Brainstem. San Diego, California:Elsevier Academic Press;1995:51–64
31. 31.↵
    1. Duvernoy HM

    . Human Brain Stem Vessels. 2nd ed. Berlin:Springer-Verlag;1999:206–18
32. 32.↵
    1. Drayer B,
    2. Burger P,
    3. Darwin R,
    4. et al

    . MRI of brain iron. AJR Am J Roentgenol 1986;147:103–10

    PubMedWeb of Science
33. 33.↵
    1. Braak H,
    2. Braak E

    . Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adult. Hum Neurobiol 1986;5:71–82

    PubMedWeb of Science
34. 34.↵
    1. Yelnik J,
    2. François C,
    3. Percheron G,
    4. et al

    . Golgi study of the primate substantia nigra. I. Quantitative morphology and typology of nigral neurons. J Comp Neurol 1987;265:455–72

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Zecca L,
    2. Pietra R,
    3. Goj C,
    4. et al

    . Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain. J Neurochem 1994;62:1097–101

    PubMedWeb of Science
36. 36.↵
    1. Double K,
    2. Gerlach M,
    3. Schünemann V,
    4. et al

    . Iron-binding characteristics of neuromelanin of the human substantia nigra. Biochem Pharmacol 2003;66:489–94

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Rutledge JN,
    2. Hilal SK,
    3. Silver AJ,
    4. et al

    . Study of movement disorders and brain iron by MR. AJR Am J Roentgenol 1987;149:365–79

    PubMedWeb of Science
38. 38.↵
    1. Tosk J,
    2. Holshouser B,
    3. Aloia R,
    4. et al

    . Effects of the interaction between ferric iron and L-dopa melanin on T1 and T2 relaxation times determined by magnetic resonance imaging. Magn Reson Med 1992;26:40–45

    CrossRefPubMed
39. 39.↵
    1. Drayer B,
    2. Olanow W,
    3. Burger P,
    4. et al

    . Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 1986;159:493–98

    PubMedWeb of Science
40. 40.↵
    1. Braffman BH,
    2. Grossman RI,
    3. Goldberg HI,
    4. et al

    . MR imaging of Parkinson disease with spin-echo and gradient-echo sequences. AJR Am J Roentgenol 1989;152:159–65

    PubMedWeb of Science
41. 41.↵
    1. Martin W,
    2. Wieler M,
    3. Gee M

    . Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008;70:1411–17

    Abstract/FREE Full Text
42. 42.↵
    1. Dexter DT,
    2. Carayon A,
    3. Javoy-Agid F,
    4. et al

    . Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991;114:1953–75

    Abstract/FREE Full Text
43. 43.↵
    1. Drayer BP

    . Imaging of the aging brain. Part II. Pathologic conditions. Radiology 1988;166:797–806

    PubMedWeb of Science
44. 44.↵
    1. Stern M,
    2. Braffman B,
    3. Skolnick B,
    4. et al

    . Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 1989;39:1524–26

    Abstract/FREE Full Text
45. 45.↵
    1. Ordidge R,
    2. Gorell J,
    3. Deniau J,
    4. et al

    . Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med 1994;32:335–41

    CrossRefPubMedWeb of Science
46. 46.↵
    1. Gorell J,
    2. Ordidge R,
    3. Brown G,
    4. et al

    . Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 1995;45:1138–43

    Abstract/FREE Full Text
47. 47.↵
    1. Bunzeck N,
    2. Duzel E

    . Absolute coding of stimulus novelty in the human substantia nigra/VTA. Neuron 2006;51:369–79

    CrossRefPubMedWeb of Science
48. 48.↵
    1. D'Ardenne K,
    2. McClure SM,
    3. Nystrom LE,
    4. et al

    . BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science 2008;319:1264–67

    Abstract/FREE Full Text